PROCONVULSANT ACTIONS OF INTRAHIPPOCAMPAL BOTULINUM NEUROTOXIN B IN THE RAT

Botulinum neurotoxins (BoNTs) may affect the excitability of brain circuits by inhibiting neurotransmitter release at central synapses. There is evidence that local delivery of BoNT serotypes A and E, which target SNAP-25, a component of the release machinery specific to excitatory synapses, can inhibit seizure generation. BoNT serotype B (BoNT/B) targets VAMP2, which is expressed in both excitatory and inhibitory terminals. Here we assessed the effects of unilateral intrahippocampal infusion of BoNT/B in the rat on intravenous pentylenetetrazol (PTZ) seizure thresholds, and on the expression of spontaneous behavioral and electrographic seizures. Infusion of BoNT/B (500 and 1000 unit) by convection-enhanced delivery caused a reduction in myoclonic twitch and clonic seizure thresholds in response to intravenous PTZ beginning about 6 days after the infusion. Handling-evoked and spontaneous convulsive seizures were observed in many BoNT/B-treated animals but not in vehicle-treated controls. Spontaneous electrographic seizure discharges were recorded in the dentate gyrus of animals that received local BoNT/B infusion;In addition, there was an increased frequency of interictal epi-leptiform spikes and sharp waves at the same recording site. BoNT/B-treated animals also exhibited tactile hyper-responsivity in comparison with vehicle-treated controls. This is the first demonstration that BoNT/B causes a delayed pro-convulsant action when infused into the hippocampus. Local infusion of BoNT/B could be useful as a focal epilepsy model. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.